Emotion recognition in early Parkinson's disease patients undergoing deep brain stimulation or dopaminergic therapy: a comparison to healthy participants
Parkinson’s disease (PD) is traditionally regarded as a neurodegenerative movement disorder, however, nigrostriatal dopaminergic degeneration is also thought to disrupt non-motor loops connecting basal ganglia to areas in frontal cortex involved in cognition and emotion processing. PD patients are i...
Main Authors: | Lindsey G. McIntosh, Sishir eMannava, Corrie R Camalier, Brad S. Folley, Aaron eAlbritton, Peter E. Konrad, David eCharles, Sohee ePark, Joseph eNeimat |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2015-01-01
|
Series: | Frontiers in Aging Neuroscience |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fnagi.2014.00349/full |
Similar Items
-
Apomorphine and Levodopa Infusion Therapies for Advanced Parkinson’s Disease
by: Angelo Antonini
Published: (2009-05-01) -
Dopaminergic agents: back to the basics – a small review
by: Neha Sharma, et al.
Published: (2017-12-01) -
Effect of Dopaminergic Medication on Postural Sway in Advanced Parkinson’s Disease
by: Fredy J. Revilla, et al.
Published: (2013-12-01) -
Systematic Evaluation of DBS Parameters in the Hemi-Parkinsonian Rat Model
by: Soheil Mottaghi, et al.
Published: (2020-10-01) -
An Integrative Approach to Treat Parkinson's Disease: Ukgansan Complements L-Dopa by Ameliorating Dopaminergic Neuronal Damage and L-Dopa-Induced Dyskinesia in Mice
by: Eugene Huh, et al.
Published: (2019-01-01)